# Catalog Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/catalog-technologies

- Industry: Software
- Headquarters: Boston, US
- Website: www.catalogdna.com
- Total disclosed funding: $54M
- Latest round: Series B (Sep 30, 2021)
- Investors on record: 22

## About

Catalog Technologies, Inc. leverages synthetic DNA for innovative data storage solutions, aiming to enhance data management and computational efficiency for various industries.Founded in 2016, Catalog Technologies, Inc. operates out of Boston, US, focusing on advanced data storage solutions using synthetic DNA technology.In March 2026, Biomemory SAS, a portfolio company of Bpifrance Investissement, EureKARE SA, Prunay Impact Studio, Adnexus, Blast.Club, Credit Mutuel Equity, Next Sequence, Paris Business Angels, Prunay Group, and Sorbonne Finance, acquired Catalog Technologies, Inc. from Hanhwa Solutions Chemical Division, Airbus Ventures, Horizons Ventures, Day One Ventures, Line Corporation, AME Cloud Ventures, DCVC, Prelude Ventures, Starlight Ventures, Kauffman Fellows, Baidu Ventures, Green Bay Ventures, Anorak Ventures, Pathbreaker Ventures, IndieBio, Awaken Capital, Wilson Sonsini Goodrich & Rosati, Sherpa Capital, Industry Ventures, StarVest Partners, New Enterprise Associates, and SOSV.Hyunjun Park is both the Founder and CEO, leading the company in its innovative mission.Catalog Technologies, Inc. specializes in synthetic DNA solutions for data storage and computational processes. Their technology addresses the challenges posed by traditional computing systems, providing efficient data storage and analysis, particularly for life sciences, pharmaceuticals, and data analytics sectors. By utilizing DNA's inherent properties, the company enables long-term preservation and processing of vast data volumes with minimal physical infrastructure requirements, primarily targeting customers in North America and Europe.Catalog Technologies, Inc. operates on a B2B revenue model through subscription agreements that grant organizations access to its DNA-based technology, facilitating significant cost savings in data management while enhancing operational efficiency. Their flagship product integrates DNA encoding for data storage, allowing clients to derive critical insights from their data archives without dependence on conventional data centers.The March 2026 acquisition enables Biomemory SAS to obtain key patents, industrial DNA-writing machines, technical experts, and infrastructure to accelerate the development and commercialization of DNA-based data storage products for data center use.

## Funding rounds

- Series B, Sep 30, 2021, $35M — Hanwha Solutions Chemical Division, SOSV, Horizons Ventures
- Series A, Sep 8, 2020, $10M — Horizons Ventures, Airbus Ventures
- Series A, Mar 25, 2020 — SOSV, IndieBio
- Seed, Jun 26, 2018, $4M — New Enterprise Associates, StarVest Partners, Industry Ventures, Prelude Ventures, Wilson Sonsini Goodrich & Rosati, DCVC, AME Cloud Ventures, Line Corporation, Awaken Capital, Green Bay Ventures, Day One Ventures, Starlight Ventures
- Seed, Jul 12, 2017, $5M — New Enterprise Associates, StarVest Partners, Industry Ventures, Sherpa Capital, SOSV, Wilson Sonsini Goodrich & Rosati, Awaken Capital, IndieBio, Pathbreaker Ventures, Anorak Ventures, Green Bay Ventures, Baidu Ventures, Kauffman Fellows, Starlight Ventures
- Seed, Oct 11, 2016, $0.3M — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Seed
- StarVest Partners (https://capitalatlas.ai/funds/starvest-partners) — Seed
- Industry Ventures (https://capitalatlas.ai/funds/industry-ventures) — Seed
- Sherpa Capital (https://capitalatlas.ai/funds/sherpa-capital) — Seed
- Wilson Sonsini Goodrich & Rosati — Seed
- Awaken Capital (https://capitalatlas.ai/funds/awaken-capital) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed, Series A
- Pathbreaker Ventures (https://capitalatlas.ai/funds/pathbreaker-ventures) — Seed
- Anorak Ventures (https://capitalatlas.ai/funds/anorak-ventures) — Seed
- Green Bay Ventures (https://capitalatlas.ai/funds/green-bay-ventures) — Seed
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Seed
- Kauffman Fellows (https://capitalatlas.ai/funds/kauffman-fellows) — Seed
- Starlight Ventures (https://capitalatlas.ai/funds/starlight-ventures) — Seed
- Prelude Ventures — Seed
- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed
- AME Cloud Ventures (https://capitalatlas.ai/funds/ame-cloud-ventures) — Seed
- Line Corporation — Seed
- Day One Ventures (https://capitalatlas.ai/funds/day-one-ventures) — Seed
- Horizons Ventures — Series A, Series B
- Airbus Ventures (https://capitalatlas.ai/funds/airbus-ventures) — Series A
- Hanwha Solutions Chemical Division — Series B
